<DOC>
	<DOCNO>NCT02944760</DOCNO>
	<brief_summary>Chronic kidney disease renal injury progressive irreversible loss kidney function advance stage call chronic renal failure . Although hemodialysis replace kidney function , patient suffer alteration characterize `` uremic syndrome '' typically express : motor neuropathy and/or autonomic neuropathy , cardiac musculoskeletal myopathy , peripheral vascular change , among others . Thus , functional capacity ability exercise present diminish patient . The aim study verify acute effect low level laser therapy functional capacity individual . The research develop hemodialysis unit Santa Clara hospital Santa Casa de Misericordia de Porto Alegre patient evaluate immediately application laser therapy protocol . Before protocol evaluate pain lower limb , Borg scale , level physical activity International Physical Activity Questionnaire ( IPAQ ) blood collection hold later analysis parameter biochemical oxidative stress deoxyribonucleic acid ( DNA ) damage . The laser therapy protocol apply 6 point quadriceps 4 point gastrocnemius , bilaterally . After application , hold 6-minute walk test , effort subjective perception Borg scale , assessment pain low limbs visual analog scale new blood sample analysis . Patients randomize two group . The intervention group ( IG ) , hold laser therapy placebo group ( PG ) , laser therapy placebo mode apply . The application take place Chattanooga device , laser diode cluster probe manufacturer consist five diode 850 nanometer ( nm ) power output 200 milliwatt ( mW ) . It irradiate 6 point quadriceps 4 point gastrocnemius , bilaterally .</brief_summary>
	<brief_title>Low-level Laser Therapy Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Patients chronic kidney disease hemodialysis 3 month ; Clearance urea hemodialysis ( Kt/V â‰¥ 1.2 ) . Cognitive impairment prevents conduct evaluation , well inability understand sign inform consent form ; Epidermal lesion site application and/or intolerance stimulator and/or skin sensitivity change ; Patients recent sequel stroke ; Disabling musculoskeletal disease ; Uncontrolled hypertension ( Systolic blood pressure &gt; 230 mmHg diastolic blood pressure &gt; 120 mmHg ) ; Grade IV heart failure ( NYHA ) decompensated ; Uncontrolled diabetes ( blood glucose &gt; 300 mg/dL ) ; Unstable angina ; Fever and/or infectious disease ; Recent acute myocardial infarction ( two month ) ; Active smoker ; Peripheral vascular disease lower limbs deep vein thrombosis obliterate thromboangiitis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>